Similar articles

• [Presence of antibodies against rifampicin in patients under tuberculostatic treatment].

  Ion N, Jemma I, Sfetcu V. Ion N, et al. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981 Jan-Mar;30(1):39-42. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981. PMID: 6264569 Romanian.
• Adverse reactions during rifampicin treatment.

  Riska N, Mattson K. Riska N, et al. Scand J Respir Dis. 1972;53(2):87-96. Scand J Respir Dis. 1972. PMID: 5052728 No abstract available.
• ["Immuno-allergic" complications of rifampicin therapy].

  Bessot JC, Vandevenne A, Petitjean R, Burghard G. Bessot JC, et al. Poumon Coeur. 1977;33(2):107-15. Poumon Coeur. 1977. PMID: 560692 French.
• Adverse reactions to rifampicin given in daily regimens: a review.

  Gupta PR. Gupta PR. J Indian Med Assoc. 1990 Sep;88(9):263-4. J Indian Med Assoc. 1990. PMID: 2286764 Review. No abstract available.
• [Rifampicin and its clinical use].

  Fafrowicz B. Fafrowicz B. Wiad Lek. 1971 Jul 1;24(3):233-8. Wiad Lek. 1971. PMID: 4926926 Review. Polish. No abstract available.